Livongo Builds Team to Expand from Diabetes to Multiple Chronic Conditions
Mountain View, CA: September 21, 2017 – Livongo Health, the leading consumer digital health company focused on empowering all people with chronic conditions to live healthier and happier lives, announced today the addition of Dr. Bimal Shah, MD, MBA, FACC, a practicing non-invasive cardiologist, as Senior Vice President for Clinical and Strategic Partnerships. This appointment supports Livongo’s expansion to hypertension and the increasing demand to provide solutions for people living with multiple chronic conditions.
“Dr. Bimal Shah brings extensive heart disease knowledge to Livongo,” said Dr. Jennifer Schneider, Chief Medical Officer of Livongo Health. “His clinical experience coupled with his experience building data-driven healthcare products will play a critical role in Livongo’s expansion to hypertension and beyond.”
As Senior Vice President for Clinical and Strategic Partnerships, Dr. Shah will provide clinical guidance on Livongo’s hypertension product. Shah will also advance Livongo’s key ecosystem relationships.
Previously, Dr. Shah was the Chief Officer for Emerging Technology and Informatics at Premier Inc., (NASDAQ: PINC). Prior to Premier, Dr. Shah served as an Assistant Professor in both the Department of Medicine and Fuqua School of Business at Duke University. Dr. Shah remains on faculty at Duke as a practicing cardiologist and serves as a member of both the Board of Advisors for the Duke School of Nursing and Board of Visitors for the University of North Carolina at Chapel Hill. Dr. Shah graduated from the University of North Carolina at Chapel Hill with a Bachelor of Arts in Economics and Chemistry, with highest honors, and earned both an MD and MBA from Duke University. Dr. Shah completed his residency in Internal Medicine at Stanford University before finishing a general cardiology fellowship at Duke University.
“I am very excited to pair my medical experiences with the programs that Livongo has developed to empower people to better manage multiple chronic conditions,” said Dr. Shah. “Livongo’s expansion to hypertension is revolutionary in the healthcare industry and I truly look forward to driving the progress ahead.”
Livongo’s digital platform for diabetes management has been implemented by over 200 leading Fortune 500 companies, innovative health systems, and the largest health plans and pharmacy benefit managers, with more than 50,000 people with diabetes enrolled today.
About Livongo Health
Livongo is the leading consumer digital health company that empowers all people with chronic conditions to live better and healthier lives. We have developed a completely new approach for chronic condition management, starting with diabetes, that combines the latest technology with coaching. By offering the right information, tools, and support, at the right time, we provide our members with real-time, personalized insights and support to make managing diabetes and multiple chronic conditions easier. Our approach is leading to better financial and clinical outcomes while also creating a better experience for people with chronic conditions and their care team of family, friends, and medical professionals. For more information visit: www.livongo.com.
View and download Livongo’s latest images for media use at www.livongo.com/press